首页|疏肝和胃方治疗肝胃不和型难治性胃食管反流病随机对照研究

疏肝和胃方治疗肝胃不和型难治性胃食管反流病随机对照研究

扫码查看
目的 评价疏肝和胃方治疗肝胃不和型难治性胃食管反流病(rGERD)的临床疗效及对肠道菌群的影响。方法 选取肝胃不和型rGERD患者80例,按随机数字表法分为试验组和对照组,每组40例。试验组予疏肝和胃方,对照组予艾司奥美拉唑镁肠溶片联合枸橼酸莫沙必利分散片,均连续治疗8周。观察两组治疗前、治疗4周、治疗8周的中医证候评分、胃食管反流病问卷(GERD-Q)量表评分变化;应用16S rDNA高通量测序检测治疗前、治疗8周后肠道菌群OUT数量、多样性及其丰度变化情况。结果 最终纳入分析80例,其中试验组40例,对照组40例。与本组治疗前比较,两组治疗4、8周中医证候评分、GERD-Q量表评分均降低(P<0。05)。与对照组同期比较,试验组治疗4周后中医证候评分降低(P<0。05);治疗8周后中医证候评分、GERD-Q量表评分均降低(P<0。05),试验组有效率高于对照组(P<0。05)。经Alpha多样性分析,试验组治疗8周后,Chao1、Ace、sobs指数均升高(P<0。05)。经菌群物种组成和丰度分析,在门水平上两组内、组间比较差异无统计学意义(P>0。05)。在属水平,试验组治疗8周后,罕见小球菌属、颤螺旋菌属、果胶单核菌属相对丰度升高(P<0。05),瘤胃球菌属相对丰度下降(P<0。05)。结论 与优化PPI联合莫沙必利方案相比,疏肝和胃方对缓解肝胃不和型rGERD临床症状效果更佳,其机制可能与调节肠道菌群多样性及部分菌属丰度有关。
Effect of Shugan Hewei Formula on Intestinal Flora in Treatment of Refractory Gastroesophageal Reflux Disease with Gan-Wei Disharmony:A Randomized Controlled Trial
Objective To evaluate the clinical efficacy and effect on intestinal flora of Shugan Hewei Formula(SGHWF)in the treatment of refractory gastroesophageal reflux disease(rGERD)with Gan-Wei disharmony syndrome.Methods Totally 80 rGERD patients with Gan-Wei disharmony were assigned to the treatment group and the control group by random number table,40 cases in each group.The treatment group was given SGHWF,and the control group was given Esomeprazole magnesium enteric-coated tablets combined with Mosapride citrate dispersible tablets for 8 consecutive weeks of treatment.The changes of Chinese medicine(CM)syndrome,Gastroesophageal Reflux Disease Questionnaire(GERD-Q)scores were observed in the two groups before treatment,and at 4 weeks and 8 weeks of treatment.The changes of intestinal bacterial flora OUT number,diversity,and its abundance were detected after 8 weeks of treatment by applying high throughput sequencing of 16S rDNA.Results Totally 80 cases were finally included in the statistical analysis,40 cases completed the trial in the treatment group and 40 cases in the control group.Compared with baseline,the CM syndrome,GERD-Q scale score were reduced in both groups after 4 weeks and 8 weeks of treatment(P<0.05).Compared with the same period of the control group,the CM syndrome score of the treatment group decreased after 4 weeks of treatment(P<0.05);the CM syndrome,GERD-Q scale score decreased after 8 weeks of treatment(P<0.05),and the effective rate of the treatment group was higher than that of the control group(P<0.05).After Alpha diversity analysis,Chao1,Ace and sobs indices were increased in the test group after 8 weeks of treatment(P<0.05).Upon analysis of species composition and abundance of the flora,there was no significant difference between the two groups in intra-and inter-group comparisons at the phylum level(P>0.05).At the genus level,the relative abundance of Subdoligranulum,norank_f__Oscillospiraceae,and Monoglobus increased after 8 weeks of treatment in the test group(P<0.05),and the relative abundance of Ruminococcus_gnavus_group decreased(P<0.05).Conclusion Compared with the optimized PPI combined with Mosapride regimen,SGHWF was more effective in relieving clinical symptomsof rGERD with Gan-Wei disharmony,and its mechanism might be related to the regulation of the diversity of the intestinal flora and the abundance of bacterial genera.

refractory gastroesophageal reflux diseaseShugan Hewei Formulaefficacy evaluationintestinal floraChinese berbal compoundintegrative medicinerandomized controlled trial

张楠、程艳梅、苏师予、朱生樑、王宏伟、徐亭亭、王磊、杨嘉、胡紫凌、王美琪

展开 >

上海中医药大学附属岳阳中西医结合医院消化内科(上海 200437)

上海市普陀区人民医院中医科(上海 200060)

难治性胃食管反流病 疏肝和胃方 临床疗效 肠道菌群 中药复方 中西医结合 随机对照试验

上海中医药大学校级项目

A2-X19026

2024

中国中西医结合杂志
中国中西医结合学会 中国中医科学院

中国中西医结合杂志

CSTPCD北大核心
影响因子:2.149
ISSN:1003-5370
年,卷(期):2024.44(4)
  • 29